The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

February 28, 2013

Conditions
Diabetic Foot Ulcer of Neuropathic Origin
Interventions
DRUG

Trafermin 0.01% spray

For ulcers with a maximum diameter (longest axis) of less or equal to 6 cm, the daily dose of trafermin 0.01% spray is 5 puffs (30 microgram) sprayed onto the wound surface. If the maximum diameter (longest axis) of the ulcer is \>6 cm, the ulcer should be sprayed in two parts, i.e. 5 puffs (30 microgram) sprayed onto each half of the wound surface

Trial Locations (24)

1036

Budapest

1095

Budapest

1097

Budapest

10034

Prague

14021

Prague

15006

Prague

18200

Prague

70300

Ostrava- Vitkovice

Unknown

Bron

Lisieux

Montpellier

Kisvárda

Sátoraljaújhely

Szeged

Szekszárd

Abbiategrasso

Campobasso

Milan

Montfalcone

Padua

Paola

Pisa

Pistoia

Rome

Sponsors
All Listed Sponsors
lead

Olympus Biotech Corporation

INDUSTRY